Moderna : AACR INT Head & Neck Poster -April 08, 2024 at 04:52 pm EDT
CT141 mRNA-4157 Individualized Neoantigen Therapy +...
Source: marketscreener.com
📰 Step Pharma News
Step Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Step Pharma. Real-time updates on events, politics, business and more.
Step Pharma announces promising pre-clinical cancer data
Step Pharma says pre-clinical data on its first-in-class, highly selective, orally bioavailable CTPS1 inhibitor, STP938 is encouraging.
Source: labiotech.eu
Investegate |Step Pharma Announcements | Step Pharma: Step Pharma to Present Promising Data on the Therapeutic Potential of Selective Small Molecule Inhibition of CTPS1 at the 64th American Society of Hematology Annual Meeting
Investegate announcements from Step Pharma, Step Pharma to Present Promising Data on the Therapeutic Potential of Selective Small Molecule Inhibition of CTPS1 at the 64th American Society of Hematology Annual Meeting
Source: investegate.co.uk
TRIANA Biomedicines, Inc.: TRIANA Biomedicines Attracts Leading Protein Science and Clinical Oncology Experts to its Scientific Advisory Board
Robert A. Copeland, PhD and Adrian M. Senderowicz, MD join Scientific Advisory BoardWALTHAM, MA / ACCESSWIRE / June 23, 2022 / TRIANA Biomedicines, Inc. (TRIANA), a leading biopharmaceutical company focused
United States John Karanicolas Patrick Trojer Roberta Copeland Adrian Senderowicz Adrianm Senderowicz
Source: finanznachrichten.de
TRIANA Biomedicines Attracts Leading Protein Science and Clinical Oncology Experts to its Scientific Advisory Board
Press release content from Accesswire. The AP news staff was not involved in its creation.
United States John Karanicolas Patrick Trojer Roberta Copeland Adrian Senderowicz Adrianm Senderowicz
Source: apnews.com
Oncoinvent appoints Adrian Senderowicz MD to its Board of Directors
Company adds experienced clinical development expert to its board of directorsOSLO, Norway--(BUSINESS WIRE)--Oncoinvent AS announces that Adrian Senderowicz was elected as a Non-executive Director today at the Company's Extraordinary General Meeting.Adrian Senderowicz is a US Board certified medical oncologist, and...
Jana Alfheim Royh Larsen Adrian Senderowicz Jonas Einarson Oncology Drug Development Us National Cancer Institute
Source: pharmiweb.com
Oncoinvent AS: Oncoinvent appoints Adrian Senderowicz MD to its Board of Directors
Company adds experienced clinical development expert to its board of directors Oncoinvent AS announces that Adrian Senderowicz was elected as a Non-executive Director today at the Company's Extraordinary
Jana Alfheim Kostenloser Wertpapierhandel Royh Larsen Adrian Senderowicz Jonas Einarson Oncology Drug Development
Source: finanznachrichten.de
Step Pharma Appoints Experienced Cancer Drug Developer Adrian Senderowicz to Board of Directors
Step Pharma, a biotech company developing novel drugs for oncology and autoimmune diseases, announced today the appointment of Dr. Adrian Senderowicz to its Board of Directors. Dr. Senderowicz is a board-certified
France General Andrew Parker Kostenloser Wertpapierhandel Sylvain Latour Adrian Senderowicz Mike Sinclair
Source: finanznachrichten.de
Bio Farma Jalin Kerja Sama dengan Google Cloud Indonesia
Bio Farma akan melakukan implementasi transformasi digital serta percepatan peluncuran produk di pasar time to market dengan menggunakan Produk Google Cloud.
Ministry Health Development Bioinformatics Information Technology Pharma Interlace Work Same Parent Pharmacy Signing Memoranda
Source: jawapos.com
Evotec AG: Evotec SE Reports Results for The First Quarter 2021 and Provides Corporate Update
Evotec AG: Evotec SE Reports Results for The First Quarter 2021 and Provides Corporate Update GOOD PROGRESS WITHIN PRODUCT DEVELOPMENT PARTNERSHIPS AND CO-OWNED PORTFOLIO CONTINUED POSITIVE FINANCIAL PERFORMANCE; NO MATERIAL IMPACT THROUGH COVID-19 PANDEMIC HAMBURG, GERMANY / ACCESSWIRE / May 11, 2021 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced the financial results and corporate updates for the first quarter 2021. HIGHLIGHTS RECORD LIKE-FOR-LIKE...
Source: finanznachrichten.de